Polyphyllin B induces ferroptosis in triple-negative breast cancer by inactivating NRF2

Ping Deng1, Shouhai Zhu2, Yuxuan Wu3

  • 1Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Abstract

Insights

Polyphyllin B (PB) effectively inhibits triple-negative breast cancer (TNBC) cell growth and migration. This natural compound induces ferroptosis by inactivating the NRF2 pathway, showing promise for TNBC treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited therapeutic options.
  • Polyphyllin B (PB), a saponin from Paris formosana Hayata, exhibits potential anticancer properties.
  • The anti-TNBC effects and specific mechanisms of PB remain largely unexplored.

Purpose of the Study:

  • To investigate the efficacy of Polyphyllin B (PB) against triple-negative breast cancer (TNBC) cells.
  • To elucidate the underlying molecular mechanisms of PB's anti-TNBC activity.
  • To evaluate PB's therapeutic potential in a preclinical TNBC mouse model.

Main Methods:

  • Cell viability, migration, and colony formation assays were used to assess PB's effects on TNBC cell lines.
  • Ferroptosis markers, including iron levels and malondialdehyde (MDA), were analyzed.
  • Molecular mechanisms were explored via Western blot, RT-qPCR, immunofluorescence, molecular docking, and a TNBC mouse model, focusing on the NRF2 pathway.

Main Results:

  • PB significantly reduced TNBC cell proliferation and migration in vitro.
  • PB treatment led to iron accumulation and increased MDA levels, indicating ferroptosis induction.
  • In vitro and in vivo, PB suppressed tumor growth, downregulated NRF2 and P62, upregulated KEAP1, and modulated ferroptosis regulators ACSL4 and GPX4.

Conclusions:

  • Polyphyllin B (PB) inhibits TNBC cell proliferation and migration by inducing ferroptosis.
  • The mechanism involves the inactivation of the NRF2 signaling pathway.
  • PB demonstrates significant potential as a therapeutic agent for triple-negative breast cancer.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...